Background: For peripheral nerve regeneration, recent attentions have been paid to the nerve conduits made by tissue-engineering technique. Three major elements of tissue-engineering are cells, molecules, and scaffolds. Method: In this study, the attachments of nerve cells, including Schwann cells, on the nerve conduit and the effects of both growth factor and adhesion molecule on these attachments were investigated. Results: The attachment of rapidly-proliferating cells, C6 cells and HS683 cells, on nerve conduit was better than that of slowly-proliferating cells, PC12 cells and Schwann cells, however, the treatment of nerve growth factor improved the attachment of slowly-proliferating cells. In addition, the attachment of Schwann cells on nerve conduit coated with fibronectin was as good as that of Schwann cells treated with glial cell line-derived neurotrophic factor (GDNF). Conclusion: Growth factor changes nerve cell morphology and affects cell cycle time. And nerve growth factor or fibronectin treatment is indispensable for Schwann cell to be used for implantation in artificial nerve conduits.
INTRODUCTION
Peripheral nerve injuries continue to be among the most challenging problems faced by surgeons. The standard approach to repair a peripheral nerve when a gap is present is to bridge the severed ends with a segment of autologous donor nerve. However, this approach incurs some donor site morbidity and usually involves secondary surgical scars. Researchers in the past have also attempted to bridge severed nerve endings with a wide variety of autologous biological tubular structures, including artery, vein, inside-out vein conduit, skeletal muscle, and decalcified bone channels. Others have used cadaveric nerve allografts or xenografts to bridge long nerve defects [1] . While investigators have achieved promising results using many of these techniques, none of these trials have produced surpassed results achieved by autograft repair [2] .
In recent, many artificial nerve conduits made of various materials have been used to study both peripheral nerve system (PNS) and central nerve system (CNS) regeneration [3] . Among them, the nerve conduit fabricated by tissue-engineering technique begins to attract new attentions because it has many advantages over those described above. It can avoid donor site morbidity and secondary surgical scars that are inevitable in autologous graft and it can also decrease graft rejection symptoms compared to allografts and xenografts. Also, the content and structure of the tissue-engineered nerve conduit can be easily modified [4] . We adopted the nerve conduit, a tissue-engineered mixture of ceramic (toothapatite), polymer (polyhydroxybutyrate-co-hydroxyvalerate, PHBV), and chitosan for this study.
It is well known that three major elements of tissue- 
MATERIALS AND METHODS

Fabrication and preparation of tissue-engineered nerve conduits
Tissue-engineered nerve conduit, polymer-ceramic composite scaffolds, composed of polyhydroxybutyrateco-hydroxyvalerate (PHBV) as a polymer, methylene chloride as a solvent, toothapatite which were made from calcination (950℃ for 1 hr) and pulverization (< 100 μm) of human teeth, and chitosan, was fabricated by a modified solvent casting and particulate leaching method with heat compression.
After gas sterilization with ethylene oxide, this nerve conduit was aseptically prepared as 5-mm cut and affixed to the bottom of a 24-well plate by 5 mg/ml collagen type I (Sigma-aldrich, St. Louis, USA) prepared in 2% acetic acid (Sigma) using its property of gelation beyond room temperature [5] . To minimize cell cytotoxicity, double-sided adhesive tape, mostly used in the previous studies [6] , was not employed.
Preparation of nerve cells
Primary Schwann cells were prepared from dorsal root ganglion (DRG) isolated from 1-day-old Sprague-Dawley rat pups (B&K Universal Ltd, Hull, UK). DRGs were treated with 0.25% collagenase (Gibco, Paisley, UK) and 0.2% DNase (Sigma) and stored in 37℃ for 1.5 hr. They were treated again by addition of 0.125% trypsin-EDTA (Sigma) and the cell mixture was stored in 37℃ for 10 min. After enzymatic solution was removed and feeding medium was added, cells were dissociated by repeated pipetting. The cell suspension was centrifuged for 10 min at 1,000 g. The cell pellet was resuspended in feeding medium, seeded on 75 ml Petri dish coated with poly-D-lysine (Sigma) and maintained in 95% air and 5% CO 2 incubator at 37℃. Feeding medium consisted of minimum essential medium (MEM, Gibco), 5% heatinactivated horse serum (HS, Gibco), 10 mg/ml glucose (Sigma), 100 units/ml penicillin and 100 μg/ml streptomycin (Gibco). After 3 days, 5 μM cytosine arabinoside (Sigma) was added to the feeding medium to suppress fibroblast proliferation. And glial cell line-derived neurotrophic factor (GDNF, Gibco) 0.2 μg/ml and cholera toxin (Sigma) 1 μg/ml were added to the feeding medium to improve Schwann cell proliferation after 3 days. The feeding medium was changed once a 2 or 3 days for 2 weeks. Schwann cells were used in passage 2 to 3.
PC12 cells (rat, pheochromocytoma, KCL 21721), C6 cells (rat, glioma, KCL 10107) and HS683 cells (human, glioma, KCL 30138) were prepared from the Korean Cell Line Bank (KCLB). PC12 cell pellets were resuspended and plated on Petri dish in RPMI1640 medium (Gibco) containing 10% heat-inactivated fetal bovine serum (FBS, Gibco) and 5% HS. C6 and HS683 cell pellets were resuspended and plated in Dulbecco's modified Eagle's medium (DMEM, Gibco) containing 10% FBS. They were maintained in 95% air and 5% CO 2 incubator at 37℃. The medium was changed once a 2 or 3 days. They were used between passage 3 to 5. 
Grouping of nerve cells
Cell seeding onto the nerve conduit and in vitro culture
To seed onto the nerve conduit, all the cells were enzymatically lifted using 0.25% trypsin-EDTA, incubated at 37℃ for 1-2 min and resuspended in known amount of medium. Cells were counted with a hemocytometer and diluted to 1X10 5 cells/ml in the medium. Aliquots of 2 ml of each cell suspension were seeded onto 5 nerve conduits respectively, prepared in a 24-well plate and maintained in 95% air and 5% CO 2 incubator at 37℃ for 48 hr.
SEM examination of cell-nerve conduit complexes
Cultured cell-nerve conduit complexes were prepared for scanning electron microscope (SEM) studies. They were incubated at low temperature in a fixative of 2.5% 
MTT assay
Cell viability through cellular attachment on the nerve conduit was measured quantitatively by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, Sigma) assay [8] . A 2 mg/ml stock solution of MTT was prepared in PBS and stored in the dark at 4℃ after filtering (0.22 μm). 50 μl of MTT dilution and 200 μl feeding medium were added to cell-nerve conduit complex. After 4 hour incubation, the supernatant was removed and 150 μl DMSO (Sigma) was added. After gentle shaking, 250 μl of solution was transferred to an ELISA microtiter plate and OD was measured at 570 nm.
Statistical analysis
All measurements (n = 5, in each group) were collected at least in triplicate and expressed as mean ± standard 
RESULTS
SEM view of the nerve conduit
The nerve conduit had hollow and round structure with 1 mm inner diameter and 0.2 mm thickness (Fig. 1A) .
SEM view revealed the inner and outer intercommunicated multi-porous surface (Fig. 1B) . The pore size was regular and fallen between 6 -8 μm. 
Cellular attachment on the nerve conduit
The attachment of PC12 cells and Schwann cells in
Group III was significantly increased compared to that of control group and Group II (P < 0.05, respectively: Fig.   3 ). There was no statistically significant difference between Group I and Group III. The relationship between cell cycle time, estimated from passage, and cellular attachment on nerve conduit was summarized in Table 1 .
SEM view of cell-nerve conduit complexes
All the cells in Group I and II were attached to both inner and outer surfaces as they sustained their own shape (Fig. 4) . But in Group III, PC12 cells with NGF treatment were morphologically changed from small and round shape to spindle shape with elongated cytoplasmic extension and reached confluency at the same 48 hr incubation ( Fig. 5A and 5C ). More elongated cytoplasmic extensons, compared to the Schwann cells in Group II, were also observed in Schwann cells treated with GDNF (Fig. 5B ) [9] . The cells in Group I and III attached to the surface of the nerve conduit as they became stratified.
In the areas of cell-nerve conduit complexes where cells were confluent, it was difficult to describe cell morphology separately.
Cellular attachment on adhesion molecule-coated nerve conduits
Seeded on tenascin-coated nerve conduits, both C6 cells and Schwann cells did not have any difference in cellular attachment compared to none-coated nerve conduit (Fig. 6 ). On fibronectin-coated nerve conduits, the cellular attachment of Schwann cells on the nerve conduit coated with 15 nM was statistically higher than that of the none-coated nerve conduit (Fig. 7) , and there was no statistically significant difference compared to the cellular attachment of Schwann cells treated with GDNF.
DISCUSSION
The prerequisite of the nerve conduits is that they can provide a controlled environment in which axons can elongate, fibrous tissue invasion is limited and humoral and cellular factors can accumulate [4] . The material used for nerve conduit in this study was originally designed as the accelerator of bone healing. As a mixture of polymer and ceramic, PHBV conferred moldability and biodegradability to this conduit and toothapatite conferred the wettability, reinforcement and biocompatibility. Also, chitosan is biodegradable cationic polyssacharide that is non-toxic, non-immunogenic and acts as a wound healing accelerator [10] . Its unique polarity could release a continuous electrical stimulation during the regrowth of severed axons [8] . Used as a nerve conduit, this material was supposed to act as a conduit allowing axons to grow through without fibrous tissue impeding during the regeneration period. to investigate the brain tumor but now they were widely accepted to study the regulatory mechanisms during neuronal regeneration process [13] . They were firstly applied to the nerve conduits for pheripheral nerve regeneration in this study.
With respects to methodology, the previous studies Tenascin was known to play a morphoregulatory role during development, tissue remodeling, and in disease by regulating the cell adhesive and signaling properties of neural and non-neural cells [16] . It is re-expressed in the adult during normal processes such as wound healing, nerve regeneration, and tissue involution, and in pathological states. Many studies showed tenascin had both adhesive and counteradhesive activities according to the condition [17] . In this study, tenascin did not improve the attachment of various nerve cells and the further study to determone the exact condition for tenascin to exert its adhesive activity.
Fibronectin was one of the most commonly used neurite promoting factors. Increased expression of fibronectin was found in damaged peripheral nerve during Wallerian degeneration [18] . When a gel mixture of collagen, laminin, and fibronectin was used to connect the ends of a severed sciatic nerve in the nerve conduit, successful regeneration of nerves across the gap occurred [19] . In conclusion, rapid-proliferating cells, without growth factor, were found to attach on the nerve conduit much better than slow-proliferating nerve cells in this study.
Though rapid-proliferating cells are mostly originated from tumor, they could present another experimental utility in peripheral nerve regeneration. Further study will be needed to prove that this higher cellular attachment will lead to better nerve regeneration. Besides, slowproliferating cells were found to improve cellular attachment on nerve conduits and altered morphological properties when treated with growth factor [21] . This findings supports the concept that growth factor changes nerve cell morphology and affects cell cycle time [22, 23] .
It is noteworthy that Schwann cells did not attach to the nerve conduit so highly as other nerve cells. However, when treated with GDNF, Schwann cells demonstrate improved attachment, not significantly different with that of rapid-dividing cells. It indicates that nerve growth factor or fibronectin treatment is indispensable for Schwann cell to be used for implantation in artificial nerve conduits.
